University of East Anglia-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2021

  1. Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

    ESMO Open, Vol. 6, Núm. 2

2016

  1. Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): A randomised, double-blind, placebo-controlled phase 3 trial

    The Lancet, Vol. 387, Núm. 10023, pp. 1066-1074